Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-015114
Filing Date
2018-03-01
Accepted
2018-03-01 17:21:46
Documents
2
Period of Report
2018-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1496
2 POA DOCUMENT poa.txt EX-24.3_774043 3073
  Complete submission text file 0001209191-18-015114.txt   6066
Mailing Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Business Address
Mineo Chrysa (Reporting) CIK: 0001575644 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36912 | Film No.: 18658994

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Issuer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)